| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1991;51:253-261
© 1991 The Society of Thoracic Surgeons
Departments of Surgery and Radiology, Kanazawa University School of Medicine, Kanazawa, Japan
Accepted for publication October 19, 1990.
* Address reprint requests to Dr Watanabe, Department of Surgery, Kanazawa University School of Medicine, 13-1 Takara-machi, Kanazawa 920, Japan.
An aggressive attitude toward surgical treatment was taken in patients with N2 non-small cell lung cancer in the past 10 years. Computed tomographic scanning was employed in the diagnosis of N2 disease, and had a true-positive rate of 57%. Among patients with N2 disease detected by computed tomographic scanning, surgical intervention was attempted except for those with unresectable disease. Of 190 patients with clinical N2 disease, 115 underwent surgical exploration: 9 patients had only an exploratory thoracotomy, 53 patients underwent a curative operation, and 53 had a noncurative operation. The overall 5-year survival rate of these patients was 16% and that of curatively resected patients was 20%. There were 47 patients whose N2 disease was not recognized before operation. The 5-year survival rate of this group was 20% overall and 33% in curatively resected cases. The overall 5-year survival rate of patients with N2 disease who underwent resection (106 with clinical N2 disease and 47 with clinically unrecognized N2 disease) was 17%, and that of the 84 patients undergoing curative operations was 24%. An aggressive attitude toward surgical intervention can be advocated for patients with N2 disease on the basis of our present results.
This article has been cited by other articles:
|
|
 |
|
  I. I. Na, J. Y. Park, K. M. Kim, G. J. Cheon, D. H. Choe, J. S. Koh, H. J. Baek, and J. C. Lee Significance of smoking history and FDG uptake for pathological N2 staging in clinical N2-negative non-small-cell lung cancer Ann. Onc., September 1, 2011; 22(9): 2068 - 2072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Detterbeck, J. Puchalski, A. Rubinowitz, and D. Cheng Classification of the Thoroughness of Mediastinal Staging of Lung Cancer Chest, February 1, 2010; 137(2): 436 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. B. Ratto, R. Costa, P. Maineri, A. Alloisio, P. Bruzzi, and B. Dozin Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection? J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 849 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Misthos, E. Sepsas, J. Kokotsakis, I. Skottis, and A. Lioulias The Significance of One-Station N2 Disease in the Prognosis of Patients With Nonsmall-Cell Lung Cancer Ann. Thorac. Surg., November 1, 2008; 86(5): 1626 - 1630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Kang, Y. J. Ra, Y. T. Kim, S.-H. Jheon, S.-w. Sung, and J. H. Kim The Impact of Multiple Metastatic Nodal Stations on Survival in Patients With Resectable N1 and N2 Nonsmall-Cell Lung Cancer Ann. Thorac. Surg., October 1, 2008; 86(4): 1092 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Mansour, E. A. Kochetkova, N. Santelmo, X. Ducrocq, E. Quoix, J.-M. Wihlm, and G. Massard Persistent N2 Disease After Induction Therapy Does Not Jeopardize Early and Medium Term Outcomes of Pneumonectomy Ann. Thorac. Surg., July 1, 2008; 86(1): 228 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Martin, A. M. Correa, W. Hofstetter, W. K. Hong, R. Komaki, J. B. Putnam Jr, D. C. Rice, W. R. Smythe, S. G. Swisher, A. A. Vaporciyan, et al. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1601 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Lorent, P. De Leyn, Y. Lievens, E. Verbeken, K. Nackaerts, C. Dooms, D. Van Raemdonck, B. Anrys, J. Vansteenkiste, and The Leuven Lung Cancer Group Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience Ann. Onc., November 1, 2004; 15(11): 1645 - 1653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Ferguson Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1935 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Kern Sounding the Mediastinum Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1261 - 1262. [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. A. Melfi, A. Chella, G. F. Menconi, F. Givigliano, G. Boni, G. Mariani, P. Sbragia, and C. A. Angeletti Intraoperative radioguided sentinel lymph node biopsy in non-small cell lung cancer Eur J Cardiothorac Surg, February 1, 2003; 23(2): 214 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Toloza, L. Harpole, F. Detterbeck, and D. C. McCrory Invasive Staging of Non-small Cell Lung Cancer: A Review of the Current Evidence Chest, January 1, 2003; 123(2009): 157S - 166S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. F. Esnaola, S. N. Lazarides, S. J. Mentzer, and K. M. Kuntz Outcomes and Cost-Effectiveness of Alternative Staging Strategies for Non-Small-Cell Lung Cancer J. Clin. Oncol., January 1, 2002; 20(1): 263 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ichinose, H. Kato, T. Koike, R. Tsuchiya, T. Fujisawa, N. Shimizu, Y. Watanabe, T. Mitsudomi, M. Yoshimura, and M. Tsuboi Completely resected stage IIIA non-small cell lung cancer: The significance of primary tumor location and N2 station J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 803 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wu, Y. Ohta, H. Minato, Y. Tsunezuka, M. Oda, Y. Watanabe, and G. Watanabe Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter Ann. Thorac. Surg., June 1, 2001; 71(6): 1772 - 1777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Andre, D. Grunenwald, J.-P. Pignon, A. Dujon, J. L. Pujol, P. Y. Brichon, L. Brouchet, E. Quoix, V. Westeel, and T. Le Chevalier Survival of Patients With Resected N2 Non-Small-Cell Lung Cancer: Evidence for a Subclassification and Implications J. Clin. Oncol., August 16, 2000; 18(16): 2981 - 2989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Yatsuyanagi, S. Hirata, K. Yamazaki, T. Sasajima, and Y. Kubo Anastomotic complications after bronchoplastic procedures for nonsmall cell lung cancer Ann. Thorac. Surg., August 1, 2000; 70(2): 396 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka Induction Therapy for Non-small Cell Lung Cancer With Involved Mediastinal Nodes in Multiple Stations Chest, July 1, 2000; 118(1): 123 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ohta, H. Nozawa, Y. Tanaka, M. Oda, and Y. Watanabe INCREASED VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR-C AND DECREASED NM23 EXPRESSION ASSOCIATED WITH MICRODISSEMINATION IN THE LYMPH NODES IN STAGE I NON-SMALL CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 804 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ohta, Y. Tomita, M. Oda, S. Watanabe, S. Murakami, and Y. Watanabe Tumor angiogenesis and recurrence in stage I non-small cell lung cancer Ann. Thorac. Surg., September 1, 1999; 68(3): 1034 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka PROGNOSIS OF COMPLETELY RESECTED pN2 NON-SMALL CELL LUNG CARCINOMAS: WHAT IS THE SIGNIFICANT NODE THAT AFFECTS SURVIVAL? J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 270 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Suzuki, K. Nagai, J. Yoshida, M. Nishimura, K. Takahashi, and Y. Nishiwaki THE PROGNOSIS OF SURGICALLY RESECTED N2 NON-SMALL CELL LUNGCANCER: THE IMPORTANCE OF CLINICAL N STATUS J. Thorac. Cardiovasc. Surg., July 1, 1999; 118(1): 145 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yano, Y. Fukuyama, H. Yokoyama, S. Kuninaka, Y. Terazaki, T. Uehara, H. Asoh, and Y. Ichinose Long-term survivors with pN2 non-small cell lung cancer after a complete resection with a systematic mediastinal node dissection Eur J Cardiothorac Surg, August 1, 1998; 14(2): 152 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vansteenkiste, P. De Leyn, G. Deneffe, J. Menten, T. Lerut, M. Demedts, and The Leuven Lung Cancer Group Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review Eur J Cardiothorac Surg, January 1, 1998; 13(1): 1 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Vansteenkiste, P. R. De Leyn, G. J. Deneffe, G. Stalpaert, K. L. Nackaerts, T. E. Lerut, and M. G. Demedts Survival and Prognostic Factors in Resected N2 Non-Small Cell Lung Cancer: A Study of 140 Cases Ann. Thorac. Surg., May 1, 1997; 63(5): 1441 - 1450. [Abstract] [Full Text]
|
|
|
|
|
|
P. Goldstraw, G. C. Mannam, D. K. Kaplan, and P. Michail Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease) J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 19 - 28. [Abstract] [Full Text]
|
|
|
|
|
|
W. Coosemans, T. E. Lerut, and D. E. M. Van Raemdonck Thoracoscopic surgery: The Belgian experience Ann. Thorac. Surg., September 1, 1993; 56(3): 721 - 730. [Abstract] [PDF]
|
|
|
|
|
|
J. C. Wain Video-assisted thoracoscopy and the staging of lung cancer Ann. Thorac. Surg., September 1, 1993; 56(3): 776 - 778. [Abstract] [PDF]
|
|
|
|
|
|
R. J. van Klaveren, J. Festen, H. J. A. M. Otten, A. L. Cox, R. de Graaf, and L. K. Lacquet Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer Ann. Thorac. Surg., August 1, 1993; 56(2): 300 - 304. [Abstract] [PDF]
|
|
|
|
|
|
E. C. M. Bollen, C. J. Van Duin, P. H. M. H. Theunissen, B. E. v./t Hof-grootenboer, and G. H. Blijham Mediastinal lymph node dissection in resected lung cancer: Morbidity and accuracy of staging Ann. Thorac. Surg., April 1, 1993; 55(4): 961 - 966. [Abstract] [PDF]
|
|
|
|
|
|
D. E. Van Raemdonck, A. Schneider, and R. J. Ginsberg Surgical treatment for higher stage non-small cell lung cancer Ann. Thorac. Surg., November 1, 1992; 54(5): 999 - 1013. [Abstract] [PDF]
|
|
|
|
|
|
I. J. Cybulsky, L. A. Lanza, M. B. Ryan, J. B. Putnam Jr, M. M. McMurtrey, and J. A. Roth Prognostic significance of computed tomography in resected N2 lung cancer Ann. Thorac. Surg., September 1, 1992; 54(3): 533 - 537. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
